Thursday, June 4, 2026

Latest:

Crackdown on massive fraud in government programs
What IRMAA actually does to your check
Major insurers share prior authorization requirements for just 14% of services: Study
June 1-5 is Medicare Fraud Prevention Week. Here’s How Americans Can Help Protect Themselves and Medicare
CMS Requires More Restrictive Definition of Medical Frailty in New Medicaid Work Requirements Rule

Alzheimer’s/Dementia

Biogen offering Aduhelm free-to-charge to some healthcare providers

Biogen, Inc., the maker of the controversial and expensive new Alzheimer’s drug, is offering the medication free of charge for

In a recent study published in Nature Neuroscience, researchers said, “if we understood why these neurons are so vulnerable, maybe

Around 6.2 million Americans aged 65 and older are living with Alzheimer’s disease. With no effective interventions for disease prevention

(By Judith Graham for Kaiser Health News) As covid-19 resurges across the country, driven by the highly infectious delta variant,

(Source – www.blogs.va.gov) Researchers with the VA Bedford and VA Boston health care systems have developed a non-invasive optical technique

(By Andrew Joseph and Rachel Cohrs for STAT) For all the explosive controversy over the approval of the first treatment

(By Jon Hamilton for NPR) Nearly two months after the Alzheimer’s drug Aduhelm received conditional approval from the Food and Drug

(By Julie Appleby for Kaiser Health News) Do you sometimes lose your train of thought or feel a bit more

(By Nick Moran for Becker’s Hospital Review) UnitedHealth Group CEO Andrew Witty said the payer needs to see more data on

(By Rachel Dolan and Elizabeth Williams for Kaiser Family Foundation published July 13, 2021) The recent approval of Aduhelm (aducanumab),